Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial of Foley Bulb Induction With and Without Simultaneous Use of Oxytocin
Brief Summary: This study is considering current standard oxytocin dosing regimen in combination with Foley bulb for cervical ripening is associated with improved outcomes including greater percentage of women delivered within or less than 24 hours. The investigators will also assess other maternal and neonatal outcomes including risk of infection (i.e. chorioamnionitis), bleeding, uterine atony, cesarean delivery and use of regional analgesia.

Participants will be randomly assigned to one of the 2 arms of the study: use of oxytocin or no oxytocin while the Foley bulb is in place. As part of standard of care for inductions, Foley bulbs will be placed for all participants. Study participants who are randomly assigned to the use of oxytocin will receive oxytocin at the time the Foley bulb is placed. Study participants randomly assigned to no oxytocin will receive the oxytocin once the Foley bulb is removed.

After delivery, information will be collected from participant's chart on the outcome of pregnancy such as gestational age at delivery, type of delivery (vaginal or cesarean section), and baby's outcome (such as birth weight, APGAR scores, and any complications).


Options:
A: Arm Label: FOLEY BALLOON; Type: ACTIVE_COMPARATOR; Interventions: Device: FOLEY BALLOON | Arm Label: CERVIDIL; Type: ACTIVE_COMPARATOR; Interventions: Drug: CERVIDIL (Dinoprostone) | Intervention Type: DRUG; Name: CERVIDIL (Dinoprostone); Assigned to Arm(s): CERVIDIL | Intervention Type: DEVICE; Name: FOLEY BALLOON; Assigned to Arm(s): FOLEY BALLOON
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Oxytocin; Type: EXPERIMENTAL; Interventions: Drug: Oxytocin | Arm Label: PROMS Foley and oxytocin; Type: EXPERIMENTAL; Interventions: Drug: Oxytocin | Arm Label: PROMS no Foley bulb; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Oxytocin, PROMS Foley and oxytocin
C: Arm Label: Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Arm Label: Foley Catheter; Type: ACTIVE_COMPARATOR; Interventions: Device: Foley Catheter | Intervention Type: DEVICE; Name: Foley Catheter; Assigned to Arm(s): Foley Catheter | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol
D: Arm Label: Cervical foley & Misoprostol; Type: EXPERIMENTAL; Interventions: Device: Cervical Foley & Misoprostol | Arm Label: Misoprostol only; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol Alone | Arm Label: Cervical foley alone; Type: EXPERIMENTAL; Interventions: Device: Cervical Foley Alone | Arm Label: Cervical foley & Pitocin; Type: EXPERIMENTAL; Interventions: Device: Cervical Foley & Pitocin | Intervention Type: DEVICE; Name: Cervical Foley & Misoprostol; Assigned to Arm(s): Cervical foley & Misoprostol | Intervention Type: DRUG; Name: Misoprostol Alone; Assigned to Arm(s): Misoprostol only | Intervention Type: DEVICE; Name: Cervical Foley Alone; Assigned to Arm(s): Cervical foley alone | Intervention Type: DEVICE; Name: Cervical Foley & Pitocin; Assigned to Arm(s): Cervical foley & Pitocin

Answer: B